Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Limited has announced the cessation of 1,070,000 options due to their expiry without being exercised or converted as of June 24, 2024. This new announcement could signal a notable change in the company’s capital structure, potentially impacting stock valuations for interested investors.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
